OncoVista Innovative Therapies, Inc.

OVITOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$2356

P/E Ratio—

52W High$0.0004

52W Low$0.0001

Avg Volume5K

Open$0.00

Beta-45.23

Net Income Financials Revenue

OncoVista Innovative Therapies, Inc. (OVIT) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

OVIT · net income · updated Jun 9, 2026

Core profitability metrics

OVIT · net income · margin · TTM · CAGR

Net income was −$2.5M for FY2014 (fiscal year ending 2014-12-31), down 75.5% year-over-year. Net profit margin was —. Based on available data, OncoVista Innovative Therapies, Inc. has been profitable since at least 2010.

FY2014 Net Income−$2.5M▼ -75.5% YoY

Trailing 12M (TTM)−$3.3Mtrailing 4 quarters sum

Net Profit Margin——

YoY Change-75.5%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2010

▸ FMP /income-statement · Annual · OVIT net income history · OVIT profit margin

Annual net income data

OVIT · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2014Loss−$2.5M▼ 75.5%—$0

FY2013Loss−$1.4M▲ +11.0%—$0

FY2012Loss−$1.6M▲ +19.6%—$0

FY2011Loss−$2.0M▼ 120.0%—$0

FY2010★ First Profit$10.1M▲ +311.2%—$0

Net income vs peers (Healthcare)

OVIT vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

OncoVista Innovative Therapies, Inc.YOU

OVIT

−$2.5M-75.5%—

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

OncoVista Innovative Therapies, Inc. (OVIT) reported net income of −$2.5M for FY2014 (fiscal year ending 2014-12-31), down 75.5% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Based on available data, OncoVista Innovative Therapies, Inc. has been profitable since at least 2010. Net income reached a peak of $10.1M in FY2010. Data available for 11 fiscal years.

OncoVista Innovative Therapies, Inc.'s net profit margin was — for FY2014, based on the latest annual results.

Investors sometimes search for "OncoVista Innovative Therapies, Inc. net worth" — the company's market capitalization is a separate figure from OVIT net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

OVIT net income · 4 questions

OncoVista Innovative Therapies, Inc. is not currently profitable on an annual basis. The company reported a net loss of $2.5M for FY2014.

is OVIT profitabledoes OVIT make a profitOVIT profitabilityOVIT profitable company

▸ Source: FMP /income-statement · GAAP · OncoVista Innovative Therapies, Inc. · OncoVista Innovative Therapies, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026